Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could ...

The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over ...

We recently published 11 Stocks That Jim Cramer Recently Talked About. Danaher Corporation (NYSE:DHR) is one of the stocks ...

We recently published 10 Stocks Jim Cramer Talked About As He Said Everyone Won From Trump’s Japan Deal. Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer recently discussed. Danaher ...

Danaher Corp. will have to battle some investor accusations that the biotechnology company overhyped demand while ...

Danaher Corporation (NYSE:DHR) largely stuck to its year-end guidance following the company’s first quarter 2025 results.

Danaher stock flashed a power inflow - a key trading signal - at a price of $193.11, after which DHR rose and closed near day ...

Danaher Corporation thrives on bioprocessing demand and diagnostics resilience. Click for why, with solid execution and 80% recurring revenue, DHR offers upside.

Q2 2025 Earnings Call Transcript July 22, 2025 Danaher Corporation beats earnings expectations. Reported EPS is $1.8, expectations were $1.64. Margaux: My name is Margaux, and I’ll be your conference ...

Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective ...

Recent discussions on X about Danaher Corporation (NYSE: DHR) have centered around the company's stock performance and strategic partnerships. Many users have noted a recent slump in the stock ...

The stock's fall snapped a two-day winning streak.